Human Embryonic Stem Cells (HESC) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Embryonic Stem Cells (HESC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Human Embryonic Stem Cells (HESC) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Totipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
Segment by Application
Research
Clinical Trials
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
ESI BIO
Thermo Fisher
BioTime
MilliporeSigma (Merck)
BD Biosciences
Astellas Institute of Regenerative Medicine
Asterias Biotherapeutics
PerkinElmer
Takara Bio
Fujifilm Cellular Dynamics
Reliance Life Sciences
R&D Systems (Biotrchne)
STEMCELL Technologies
TATAA Biocenter
UK Stem Cell Bank
Viacyte, Inc.
